Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

益杰立科(上海)生物科技有限公司于2021.9.29成立,主要从事基因编辑工具的开发研究和基因治疗研发。基因治疗一直备受大家关注,是精准治疗的一大代表。益杰立科抓住机遇结合mRNA产业特点,开发相比于传统基因编辑治疗更安全、应用病症更广泛的治疗方法。

益杰立科基因编辑治疗研发平台主要面向慢性疾病群体。我们结合mRNA递送方式-纳米脂质体(LNP)进行递送,开发出不在DNA层面进行任何切割,只是沉默目的基因达到治病效果的基因编辑治疗方法。我们利用人体天然的蛋白表达调控系统,长期高效且精准干预目的基因的表达,达到长效抑制或者有治愈慢性疾病的可能。

益杰立科目前研发团队皆是行业优秀科学人才,硕博比例占比80%,研发人员占比70%,同时具有行业资深生物医药研发管理团队,能快速布局和推进研发管线。我们将打造成为全自主知识产权研发平台,始终致力于慢性疾病创造新的治疗方式,真正摆脱老年慢性疾病、慢性疾病的困扰,为医学做出一份贡献。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

益杰立科 Financing History (5 rounds)

Manage
B轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 6000万美元
  • Investor: 龙磐投资,启明创投,奥博资...

益杰立科 How Fast Is Hiring Growing? (2 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 20%
  • 2024: Down 82%
  • 2023: Up 87%
益杰立科 Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
益杰立科 Campus Recruitment & Advanced Degree Talent Demand
Doctorate 2
Note: How fast is hiring at 益杰立科(上海)生物科技有限公司 growing? 益杰立科2025年6个(增长20%),2024年5个(下降82%),2023年28个(增长87%),2022年15个. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

益杰立科 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 300%
  • 2024: Down 89%
  • 2023: Up 200%
益杰立科 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 益杰立科(上海)生物科技有限公司 growing? 益杰立科历年硕士招聘职位量:2025年4个(增长300%),2024年1个(下降89%),2023年9个(增长200%),2022年3个.

益杰立科 Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
益杰立科 Doctoral Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 益杰立科(上海)生物科技有限公司 growing? 益杰立科历年博士招聘职位量:2026年4个(增长175%),2024年2个(下降89%),2023年15个(增长200%),2022年9个. 益杰立科在上海博士人才需求中排名第233, 益杰立科博士工资大部分在30-50K.

益杰立科 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 益杰立科(上海)生物科技有限公司? Based on an analysis of 益杰立科's job postings over the past year, “生物/制药/化工/环保类”需求占45.8%,“科研类”占41.7%,“其他(研发和技术类)”占33.3%,“医疗卫生/美容保健类”占20.8%,“计算机/网络/技术类”占8.3%. For reference only.

益杰立科 — What Are the Salaries Like? (24 records)

Manage
益杰立科 Salary Overview
salary range: 8K - 50K, 75% of roles pay ¥10-30K
Note: salary statistics are based on 24 salary records from the past year and depend on the job sample. For reference only.
益杰立科(上海)生物科技有限公司工资待遇怎么样?益杰立科75%的岗位拿10-30K,本科工资¥。与同行业比+14%,生物/制药/化工/环保类平均工资¥23.6K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 益杰立科

(More)
Are salaries high at 益杰立科(上海)生物科技有限公司? We provide: 分析,研究员,科学家,ra,生产工,系统研发,临床,医学经理,深度学习,高级经理. Click to view detailed salary analysis by job.

益杰立科 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

益杰立科 Related Industry Tags

Job Category

  • 生物/制药/化工/环保类
    45.8% of total 45.8%
  • 科研类
    41.7% of total 41.7%
  • 其他(研发和技术类)
    33.3% of total 33.3%
  • 医疗卫生/美容保健类
    20.8% of total 20.8%

Education

  • 硕士
    54.2% of total 54.2%
  • 本科
    29.2% of total 29.2%
  • 博士
    16.7% of total 16.7%

Experience

  • 1-3年
    54.2% of total 54.2%
  • 3-5年
    37.5% of total 37.5%
  • 5-10年
    4.2% of total 4.2%
  • 不限
    4.2% of total 4.2%
View Detailed Analysis

What does 益杰立科(上海)生物科技有限公司 require? Who is 益杰立科 hiring? 益杰立科招聘类别生物/制药/化工/环保类占比最多占45.8%,其次是科研类占41.7%。益杰立科什么学历能进?硕士占比最多占54.2%,其次是本科占29.2%。益杰立科学历要求高吗?硕士占54.2%,博士占16.7%。工作经验益杰立科有什么要求?1-3年占比最多占54.2%,其次是3-5年占37.5%。益杰立科工作地区在哪?上海占比最多占100%。 Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 150万(元)
Legal Representative: 刘莹莹
Date Established:
Credit Code: 91310115MA7B8HH24B
Registered Address: 中国(上海)自由贸易试验区巴圣路160号7幢1单元1层A1014号工位

Partners & Suppliers

提供临床前安全性评价服务,双方签订战略合作协议。 Source
供应商 临床前CRO
提供细胞系开发及生产服务,助力细胞治疗产品开发。 Source
供应商 CDMO
提供基因合成及CRO服务,支持基因编辑技术开发。 Source
供应商 基因合成/CRO

People who follow 益杰立科 also follow

益杰立科 Competitors (Similar Companies)

“专注于核酸诊断试剂核心原料领域”
生物科技/生物工程 生物科技 细胞治疗 干细胞
“湖北省医药工业的龙头企业、中国医药工业50强企业”
“科技成就生活之美”
生物科技/生物工程 医疗器械 分子诊断 自动化技术
材料科学 科学研究 研发 光学检测
生命科学试剂 生化试剂 elisa试剂盒 elisa试剂
抗体 诊断试剂 快速诊断试剂 试剂
“国内专业、全面的抗体供应商”
“不断创新为患者带来能显着改善其健康的药物”
“宏德广布, 济世养生”
制药/药业 医药 制药 医药中间体
“致力于在肿瘤、乙肝及与衰老相关的疾病等治疗领域开发创新药物”
“专注于免疫细胞治疗”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates

心理援助
客服
由百度提供